Do we need to maximise the breast cancer screening awareness? Experience with an endogamous society with high fertility
A Bener, HR El Ayoubi, MA Moore… - Asian Pac J Cancer …, 2009 - journal.waocp.org
Background: In the State of Qatar, breast cancer has become the most common form of
cancer amongwomen. The aim of this study was to explore knowledge, attitude and practice …
cancer amongwomen. The aim of this study was to explore knowledge, attitude and practice …
[PDF][PDF] Impacts of family history and lifestyle habits on colorectal cancer risk: a case-control study in Qatar
…, MA Moore, R Ali, HR El Ayoubi - Asian Pac J Cancer Prev, 2010 - researchgate.net
Background: Associations between family history of colorectal cancer (CRC) in first degree
relatives and risk of developing cancer have been well defined, but interactions with …
relatives and risk of developing cancer have been well defined, but interactions with …
[PDF][PDF] Impact of consanguinity on cancer in a highly endogamous population
A Bener, HR El Ayoubi, L Chouchane, AI Ali… - Asian Pac J Cancer …, 2009 - researchgate.net
Background: Many epidemiological studies have indicated that inbreeding has little or no
effect on the incidence of cancer. Due to the high prevalence of consanguinity in Qatar (54%), …
effect on the incidence of cancer. Due to the high prevalence of consanguinity in Qatar (54%), …
Assessing breast cancer risk estimates based on the Gail model and its predictors in Qatari women
Background: The Gail model is the most widely used breast cancer risk assessment tool. An
accurate assessment of individual’s breast cancer risk is very important for prevention of the …
accurate assessment of individual’s breast cancer risk is very important for prevention of the …
Molecular monitoring of patients with chronic myeloid leukemia (CML) in the state of Qatar: optimization of techniques and response to imatinib
NI Al-Dewik, AP Jewell, MA Yassin, HR El-Ayoubi… - QScience …, 2014 - qscience.com
Most cases of chronic myeloid leukemia (CML) are associated with the presence of BCR-ABL1
fusion gene; a molecular anomaly that introduced targeting therapy to CML. This study …
fusion gene; a molecular anomaly that introduced targeting therapy to CML. This study …
An assessment of reliability and validity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 among breast cancer …
…, L Doodson, HR El Ayoubi - Journal of family …, 2017 - journals.lww.com
Aim: This study aimed to assess psychometric properties of the Arabic version of the European
Organization for Research and Treatment of Cancer (EORTC) general QoL questionnaire …
Organization for Research and Treatment of Cancer (EORTC) general QoL questionnaire …
The role of vitamin D deficiency and osteoporosis in breast cancer
A Bener, HR El Ayoubi - International journal of rheumatic …, 2012 - Wiley Online Library
Aim Epidemiological studies suggest an association between vitamin D and calcium intake
and breast cancer. The aim of this study was to determine the association of breast cancer …
and breast cancer. The aim of this study was to determine the association of breast cancer …
Studying the impact of presence of point mutation, insertion mutation and additional chromosomal abnormalities in chronic myeloid leukemia patients treated with …
NI Al-Dewik, AP Jewell, MA Yassin, HR El-Ayoubi… - QScience …, 2014 - qscience.com
Background: Imatinib is failing as a first line treatment in more than 40% of chronic myeloid
leukemia (CML) patients in Qatar. We thus investigated ABL1 kinase domain mutations and …
leukemia (CML) patients in Qatar. We thus investigated ABL1 kinase domain mutations and …
[PDF][PDF] Breast cancer screening barriers: knowledge, attitudes and practices of women toward breast cancer
To the Editor: Breast cancer appears to be a major global health problem of both the
developing and developed countries. Global statistics show that the annual incidence of breast …
developing and developed countries. Global statistics show that the annual incidence of breast …
[HTML][HTML] Efficacy and safety of dasatinib 50 mg once daily dose in patients with chronic phase CML who failed imatinib
MA Yassin, HR El-Ayoubi, RT Kamzoul - Blood, 2011 - Elsevier
Abstract 4440 Background: Dasatinib is multi-targeted kinase inhibitor and it is approved
therapy for patients with imatinib-resistant or imatinib-intolerant CML or newly diagnosed CML (…
therapy for patients with imatinib-resistant or imatinib-intolerant CML or newly diagnosed CML (…
